Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2018-04-24

Clinical Trial Update: PRospective Study for the TrEatment of Atherosclerotic Lesions in the Superficial Femoral and/or Popliteal Arteries Using the Serranator DevicE [NA]

View source ↗

Summary

This is a completed prospective trial evaluating the Serranator Device for treating atherosclerotic lesions in the superficial femoral and/or popliteal arteries…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Serranator Device

Snippet

Sponsor: Cagent Vascular LLC | Conditions: Peripheral Arterial Disease | NA | Status: COMPLETED